← back to search

Kyle R. Covington

Duke University · US
Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Cutaneous Melanoma Detection and Management, Nonmelanoma Skin Cancer Studies, and Melanoma and MAPK Pathways.
h-index
79
citations
73,641
works
279
NIH funding
primary concept
Medicine
email

Recent publications

Developing consensus on competency-based educational standards in orthopaedic manual physical therapy fellowship training: findings from a modified Delphi part 4: systems-based practice and patient management.
2026cited by 0position: contributordoi
Developing consensus on competency-based educational standards in orthopaedic manual physical therapy fellowship training: findings from a modified Delphi: part 1: clinical reasoning.
2026cited by 0position: contributordoi
Developing consensus on competency-based educational standards in orthopaedic manual physical therapy fellowship training: findings from a modified Delphi: part 3: communication and education.
2026cited by 0position: contributordoi
Early genetic evolution of driver mutations in uveal melanoma
Nature Communications 2025cited by 2position: middledoi
31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration
JCO Precision Oncology 2023cited by 35position: middledoi
Author Correction: The repertoire of mutational signatures in human cancer
Nature 2023cited by 9position: middledoi
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction
JCO Precision Oncology 2021cited by 56position: middledoi
Does coaching in the 3 <sup>rd</sup> year of medical school affect stress, anxiety and depression?
2021cited by 0position: contributordoi
The repertoire of mutational signatures in human cancer
Nature 2020cited by 3,686position: middledoi
Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma
Journal of the American Academy of Dermatology 2020cited by 90position: middledoi
Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients
Journal of the American Academy of Dermatology 2020cited by 80position: middledoi
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
Nature Communications 2020cited by 1position: middledoi
Analysis of Clinical Education Situation (ACES) Framework: identifying the root cause of student Failure in the United States.
2019cited by 3position: contributordoi
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
Cell Systems 2018cited by 936position: middledoi
Integrated Molecular Characterization of Testicular Germ Cell Tumors
Cell Reports 2018cited by 456position: middledoi
Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer
Cell 2018cited by 147position: middledoi
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
BMC Cancer 2018cited by 141position: middledoi
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa
Science Translational Medicine 2018cited by 132position: middledoi
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
Cell Reports 2017cited by 609position: middledoi
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
Cell Reports 2017cited by 247position: middledoi
Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair
Cell 2016cited by 441position: middledoi
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
Cell Reports 2016cited by 380position: middledoi
Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates
Nature Communications 2016cited by 159position: middledoi
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation
Cell Reports 2016cited by 146position: middledoi
Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes
Nature Genetics 2015cited by 322position: middledoi
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Clinical Cancer Research 2014cited by 1,372position: middledoi
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Nature Genetics 2014cited by 774position: middledoi
Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma
Clinical Cancer Research 2014cited by 605position: middledoi
Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis
Blood 2014cited by 426position: middledoi
Leptin Mediates Tumor–Stromal Interactions That Promote the Invasive Growth of Breast Cancer Cells
Cancer Research 2012cited by 125position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2018–2023) · 4 papers (2021–2026)David A. Wheeler · St. Jude Children's Research Hospital4 papers (2014–2016)Jennifer Bent · Duke University Health System3 papers (2026–2026)Chad E Cook · Duke University3 papers (2026–2026)Megan Donaldson · Medical University of South Carolina3 papers (2026–2026)Damian Keter · Chatham University3 papers (2026–2026)Sarah J. Kurley · Baylor College of Medicine3 papers (2020–2023)Donna M. Muzny · Baylor College of Medicine3 papers (2014–2015)HarshaVardhan Doddapaneni · Baylor College of Medicine3 papers (2014–2015)Richard A. Gibbs · Baylor College of Medicine2 papers (2014–2015)Jennifer Drummond · Rice University2 papers (2014–2015)Eve Shinbrot · NeoGenomics (United States)2 papers (2014–2016)Brian Gastman · Citigroup2 papers (2018–2020) · 2 papers (2018–2020)Amy McDevitt · The University of Colorado Physical Therapy Program2 papers (2026–2026)Mark Shepherd · Bellin College2 papers (2026–2026) · 2 papers (2020–2020)Linghua Wang · The University of Texas MD Anderson Cancer Center2 papers (2014–2015)Suzanne A.W. Fuqua · Baylor College of Medicine2 papers (2012–2014)